“There’s a need for this because there’s been sort of rumblings in the scientific community that psychedelic medications may be very beneficial for patients who have PTSD, especially treatment-resistant PTSD,” Associate Professor Dr. Katherine Schafer at Vanderbilt University Medical Center Department of Biomedical Informatics said.

The parents of a decorated veteran from the mission in Afghanistan say that after almost two weeks in an Ottawa jail, their son isn't properly being given the medication he needs to treat his post-traumatic stress disorder.

Trump signed an executive order on April 18, 2026, directing the FDA and DEA to fast-track research and approval of ibogaine and psilocybin.

(Corrects name of advocacy group to Veterans Exploring Treatment Solutions in paragraph 19) By Jacob Bogage WASHINGTON, April 17 (Reuters) - U.S. President Donald Trump is set to order the federal government to reevaluate restrictions on a psychedelic drug sometimes used internationally to treat post-traumatic stress disorder and other mental health conditions,

This naturally occurring substance, derived from an African shrub, has been used to treat PTSD, brain trauma, depression, addiction and other disorders.

A powerful psychedelic plant medicine is gaining federal and state backing, and it may offer hope to those who suffer from PTSD or addictions.

Utah authorizes a state-funded clinical trial studying psychedelic-assisted therapy for veterans with treatment-resistant PTSD, marking a cautious, evidence-first approach to psychedelic research. HB390 is a necessary first-step,